ITCI Stock Price Prediction

Intra-Cellular Therapies Inc

Add to Watchlist

Advanced Chart

131.900

+0.03(0.023%)1D

Overview
Forecast
Valuation
Earnings

Should I Buy Intra-Cellular Therapies Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ITCI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

ITCI stock price ended at $131.9 on Tuesday, after losing -0.04%

The Intra-Cellular Therapies Inc stock price decreased by -0.04% on the last trading day (22 Jul 2025), dropping from 131.9 to 131.87. Throughout the last trading session, the stock experienced a fluctuation of 0.27% , ranging from a day low of $131.63 to a day high of 131.98. The price has declined in 2 of the last 10 days, resulting in a total change of 0.32% during this period. On the last day, trading volume decrease by 13.11M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 16.06M shares were traded, amounting to approximately 2.12B.

ITCI Technical Signals

ITCI(Intra-Cellular Therapies Inc Corp) has 3 buy signals and 4 sell signals now. The current trend is consolidation starting from 2025-03-04. The total price change during this trend is +0.48%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of ITCI over the last 5 trading days is 619.45M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.

ITCI Moving Average Analysis

Intra-Cellular Therapies Inc's overall moving average trend leans more bullish as of Tuesday, July 22, 2025, with 0 negative signals and 4 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $132.04, and $132.25. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $131.39, and $131.19. A break-down below any of these levels will issue sell signals.

ITCI Short Selling Analysis

The short sale ratio of Intra-Cellular Therapies Inc(ITCI) as of Invalid Date is %, dropping from last trading day. With decreasing price from to .

Technical Signal

Technical Signals Summary

Neutral

Sell

Buy

Moving Average

Swing

Positive

Stock Price Above SMA_5

Short Term

Positive

SMA_5 Above SMA_20

Mid Term

Positive

SMA_20 Above SMA_60

Long Term

Negative

SMA_60 Below SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

3 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 > 0

1.44

Bullish

Momentum (10 days)

MOM_10 > 0

0.42

Bullish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 > 0

1.32

Bullish

4 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Relative Strength Index (14 days)

RSI_14 > 70

84.54

Bearish

Stochastic Oscillator %K (14, 3, 3)

STOCHk_14_3_3 > 80

90.92

Bearish

Commodity Channel Index (20 days, 0.015 constant)

CCI_20_0.015 > 100

105.84

Bearish

Williams %R (14 days)

WILLR_14 > -20

-14.47

Bearish

ITCI Stock Forecast

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Month	Min. Price	Avg. Price	Max. Price	Potential ROI

No data

Unlock Free Stock Price Forecast

In 2026, Intra-Cellular Therapies Inc (ITCI) is anticipated to change hands in a trading channel between $0.00 and $0.00.

Intra-Cellular Therapies Inc Stock Forecast 2026

ITCI Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Intra-Cellular Therapies Inc(ITCI), our algorithm predicts ITCI's 1-month price at $132.01, with an 0.15%upwardshift. Using a similarity score up to 99.43%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for Intra-Cellular Therapies Inc (ITCI.O) stock, as of Sunday, March 30, 2025 , forecasts a 0.15% change over the next month, based on its high correlation with AFBI.O stock patterns. The similarity between their price movements over the analyzed periods is 99.43%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

ITCI

Future prediction

Up: 0.15%

AFBI

Up: 0.15%Similarity: 99.43%

Name

Similarity

Up/Down

AFBI.O

99.43%

+0.15%

GBX.N

99.42%

-5.92%

DGICB.O

99.37%

0.00%

CPS.N

99.35%

+6.21%

ONC.O

99.33%

-17.76%

CMG.N

99.31%

+7.91%

VABK.O

99.30%

-8.74%

HSII.O

99.26%

-5.14%

EFXT.N

99.22%

+6.64%

BWLP.N

99.21%

0.00%

ITCI Seasonality Analysis

Based on ITCI's historical stock price data across all years, the probability of a positive return in July is30.00%, suggesting it maynotbe an ideal month to invest in ITCI. In contrast,Februaryoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Intra-Cellular Therapies Inc (ITCI.O) stock in February has the highest probability of a positive return (72.73%), while July has the lowest probability (30.00%).

Performance Seasonality

The chart shows Intra-Cellular Therapies Inc. (ITCI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.